Hiroshi. Iwakura, et.al., A mouse model of ghrelinoma exhibited activated growth hormone-insulin-like growth factor I axis and glucose intolerance., American journal of physiology. Endocrinology and metabolism, 2009, 297

http://rdf.ncbi.nlm.nih.gov/pubmed/19602582

Hiroshi. Iwakura, et.al., A mouse model of ghrelinoma exhibited activated growth hormone-insulin-like growth factor I axis and glucose intolerance., American journal of physiology. Endocrinology and metabolism, 2009, 297

pubmed

allele

http://purl.org/net/cito/citesAsAuthority

• Tg(GHRL-TAg)3-1Hiwa
  http://metadb.riken.jp/db/mgi_rdf/MGI:4360904
• Tg(GHRL-TAg)4-3Hiwa
  http://metadb.riken.jp/db/mgi_rdf/MGI:4360906
• Tg(GHRL-TAg)1-5Hiwa
  http://metadb.riken.jp/db/mgi_rdf/MGI:4360905

class

http://purl.org/net/cito/citesAsAuthority

• Tg(GHRL-TAg)3-1Hiwa
  http://metadb.riken.jp/db/mgi_rdf/MGI:4360904
• Tg(GHRL-TAg)4-3Hiwa
  http://metadb.riken.jp/db/mgi_rdf/MGI:4360906
• Tg(GHRL-TAg)1-5Hiwa
  http://metadb.riken.jp/db/mgi_rdf/MGI:4360905

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• increased stomach tumor incidence_Tg(GHRL-TAg)3-1Hiwa/0
  http://metadb.riken.jp/0010301C57BL6TgGHRLTAg31HiwaTgGHRLTAg31Hiwa0TgGHRLTAg31Hiwa
• gastric hypertrophy_Tg(GHRL-TAg)3-1Hiwa/0
  http://metadb.riken.jp/0003285C57BL6TgGHRLTAg31HiwaTgGHRLTAg31Hiwa0TgGHRLTAg31Hiwa
• increased tumor latency_Tg(GHRL-TAg)4-3Hiwa/0
  http://metadb.riken.jp/0009828C57BL6TgGHRLTAg43HiwaTgGHRLTAg43Hiwa0TgGHRLTAg43Hiwa
• increased tumor incidence_Tg(GHRL-TAg)1-5Hiwa/0
  http://metadb.riken.jp/0002020C57BL6TgGHRLTAg15HiwaTgGHRLTAg15Hiwa0TgGHRLTAg15Hiwa
• increased pancreas tumor incidence_Tg(GHRL-TAg)1-5Hiwa/0
  http://metadb.riken.jp/0009153C57BL6TgGHRLTAg15HiwaTgGHRLTAg15Hiwa0TgGHRLTAg15Hiwa
• increased circulating glucose level_Tg(GHRL-TAg)3-1Hiwa/0
  http://metadb.riken.jp/0005559C57BL6TgGHRLTAg31HiwaTgGHRLTAg31Hiwa0TgGHRLTAg31Hiwa
• decreased food intake_Tg(GHRL-TAg)3-1Hiwa/0
  http://metadb.riken.jp/0011940C57BL6TgGHRLTAg31HiwaTgGHRLTAg31Hiwa0TgGHRLTAg31Hiwa
• impaired glucose tolerance_Tg(GHRL-TAg)3-1Hiwa/0
  http://metadb.riken.jp/0005293C57BL6TgGHRLTAg31HiwaTgGHRLTAg31Hiwa0TgGHRLTAg31Hiwa
• increased stomach tumor incidence_Tg(GHRL-TAg)1-5Hiwa/0
  http://metadb.riken.jp/0010301C57BL6TgGHRLTAg15HiwaTgGHRLTAg15Hiwa0TgGHRLTAg15Hiwa
• increased thyroid tumor incidence_Tg(GHRL-TAg)1-5Hiwa/0
  http://metadb.riken.jp/0010316C57BL6TgGHRLTAg15HiwaTgGHRLTAg15Hiwa0TgGHRLTAg15Hiwa
• decreased total body fat amount_Tg(GHRL-TAg)3-1Hiwa/0
  http://metadb.riken.jp/0010025C57BL6TgGHRLTAg31HiwaTgGHRLTAg31Hiwa0TgGHRLTAg31Hiwa
• decreased body weight_Tg(GHRL-TAg)3-1Hiwa/0
  http://metadb.riken.jp/0001262C57BL6TgGHRLTAg31HiwaTgGHRLTAg31Hiwa0TgGHRLTAg31Hiwa
• increased circulating insulin-like growth factor I level_Tg(GHRL-TAg)3-1Hiwa/0
  http://metadb.riken.jp/0004702C57BL6TgGHRLTAg31HiwaTgGHRLTAg31Hiwa0TgGHRLTAg31Hiwa
• decreased circulating insulin level_Tg(GHRL-TAg)3-1Hiwa/0
  http://metadb.riken.jp/0002727C57BL6TgGHRLTAg31HiwaTgGHRLTAg31Hiwa0TgGHRLTAg31Hiwa
• premature death_Tg(GHRL-TAg)1-5Hiwa/0
  http://metadb.riken.jp/0002083C57BL6TgGHRLTAg15HiwaTgGHRLTAg15Hiwa0TgGHRLTAg15Hiwa
• gastric hypertrophy_Tg(GHRL-TAg)4-3Hiwa/0
  http://metadb.riken.jp/0003285C57BL6TgGHRLTAg43HiwaTgGHRLTAg43Hiwa0TgGHRLTAg43Hiwa
• decreased circulating leptin level_Tg(GHRL-TAg)3-1Hiwa/0
  http://metadb.riken.jp/0005668C57BL6TgGHRLTAg31HiwaTgGHRLTAg31Hiwa0TgGHRLTAg31Hiwa